Cita APA (7a ed.)

Brunette, C. A., Dong, O. M., Vassy, J. L., Danowski, M. E., Alexander, N., Antwi, A. A., & Christensen, K. D. (2021). A Cost–Consequence Analysis of Preemptive <i>SLCO1B1</i> Testing for Statin Myopathy Risk Compared to Usual Care. MDPI AG.

Cita Chicago Style (17a ed.)

Brunette, Charles A., Olivia M. Dong, Jason L. Vassy, Morgan E. Danowski, Nicholas Alexander, Ashley A. Antwi, y Kurt D. Christensen. A Cost–Consequence Analysis of Preemptive <i>SLCO1B1</i> Testing for Statin Myopathy Risk Compared to Usual Care. MDPI AG, 2021.

Cita MLA (8a ed.)

Brunette, Charles A., et al. A Cost–Consequence Analysis of Preemptive <i>SLCO1B1</i> Testing for Statin Myopathy Risk Compared to Usual Care. MDPI AG, 2021.